I agree that this site is using cookies. You can find further informations here.
X
Aleman, Adolfo
70  results:
Search for persons X
?
1

Phase 1 study combining elotuzumab with autologous stem cel..:

Coffey, David G ; Osman, Keren ; Aleman, Adolfo...
Journal for ImmunoTherapy of Cancer.  12 (2024)  4 - p. e008110 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Interventions and outcomes of patients with multiple myelom..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Blood.  141 (2023)  7 - p. 756-765 , 2023
Link: https://doi.org/10.1182/..
 
?
3

Cellular mechanisms associated with sub-optimal immune resp..:

Aleman, Adolfo ; van Kesteren, Morgan ; Zajdman, Ariel Kogan...
eBioMedicine.  98 (2023)  - p. 104886 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Publisher Correction: A pipeline for malignancy and therapy..:

Kimmerling, Robert J. ; Stevens, Mark M. ; Olcum, Selim...
Communications Biology.  6 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
5

P-175 Improving Anti-BCMA CAR-T functionality with novel im..:

Aleman, Adolfo ; Kogan-Zajdman, Ariel ; Upadhyaya, Bhaskar...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S131-S132 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P-379 Variable humoral and cellular responses to SARS-CoV-2..:

Aleman, Adolfo ; van Kesteren, Morgan ; Kogan-Zajdman, Ariel...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S249 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P-381 Mezigdomide (CC-92480) activates innate and adaptive ..:

Chen, Lucia ; Amatangelo, Michael ; van Oekelen, Oliver...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S250 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Sequencing T-cell redirection therapies leads to deep and d..:

Mouhieddine, Tarek H. ; Van Oekelen, Oliver ; Melnekoff, David T....
Blood Advances.  7 (2023)  6 - p. 1056-1064 , 2023
Link: https://doi.org/10.1182/..
 
?
9

MM-530 Interventions and Outcomes of Multiple Myeloma Patie..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S428 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A pipeline for malignancy and therapy agnostic assessment o..:

Kimmerling, Robert J. ; Stevens, Mark M. ; Olcum, Selim...
Communications Biology.  5 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Poster: MM-530 Interventions and Outcomes of Multiple Myelo..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S184 , 2022
Link: https://doi.org/10.1016/..
 
?
12

I-OPen: inferior outcomes of penta-refractory compared to p..:

Gill, Sarvarinder K. ; Unawane, Rashmi ; Wang, Shuqi...
Blood Cancer Journal.  12 (2022)  9 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
13

OAB-053: Clinical outcomes of relapsed/refractory multiple ..:

Oekelen, Oliver Van ; Mouhieddine, Tarek ; Pan, Darren...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S38 , 2021
Link: https://doi.org/10.1016/..
 
?
14

NP-114: Lesson Learned: Management of patients with Multipl..:

Verina, Daniel ; Van Oekelen, Oliver ; Gleason, Charles...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S171 , 2021
Link: https://doi.org/10.1016/..
 
?
15

OAB-048: Suboptimal humoral immune response to SARS-CoV-2 m..:

Oekelen, Oliver Van ; Agte, Sarita ; Gleason, Charles...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S30-S31 , 2021
Link: https://doi.org/10.1016/..
 
1-15